Shahid Beheshti
University of Medical Sciences

 

1 2 3
Men's Health and Reproductive Health Research Center (MHRHRC) proudly announce its readiness to collaborate with Students , Doctors and Experts from non-faculty from various academic fields to convey their Research Ideas to national and international Professors from all over the globe and also administrative and executive activities for research projects.
Latest Headlines : 
Main Menu
Visitors` Statistics
 this page : 11638
 today : 49
 total : 67728
 online : 1
 time : 0.10
 


  Print        Send to Friend

The new research by Men's Health and Reproductive Health Research center

Background and Aim:Many recent studies have shown a direct relationship between the decrease in the expression of GSTP1 and RASSF1 with the incidence and progression of prostate cancer. Moreover, the expression level of these genes is greatly affected by epigenetic factors and their methylation pattern. Given the prevalence of prostate cancer and the importance of choosing the best method to inhibit the progression of the disease and provide specific treatment, it is important to evaluate the effect of hormone therapy on the expression of effective prostate cancer genes and epigenetic markers. Patients and Methods: In this case–control study, 35 prostate cancer samples were examined before and after hormone therapy. Following the blood sampling, RNA extraction, and cDNA synthesis, the expression of GSTP1, RASSF1, HDAC, DNMT3A, and DNMT3B was assessed by real-time PCR. Results: The results analysis showed that the expression of GSTP1, RASSF1, and DNMT3B was significantly increased, DNMT3A was significantly decreased (P value<0.05) and HDAC expression did not change significantly (P value=0.19) after hormone therapy. Discussion: Significant changes in the expression of GSTP1, RASSF1, DNMT3B and DNMT3A in the studied samples indicate that these genes are susceptible targets for cancer hormone therapy in Iranian men like in the other populations. Evaluation of gene activity in a larger population of patients may support these findings.

Keywords:GSTP1, RASSF1, HDAC, DNMT3A, DNMT3B, prostate cancer, hormone therapy, real-time PCR

 


15:19 - 2020/09/09    /    number : 96238    /    Show Count : 17







 

Men's Health and Reproductive Health Research Center

Shahid Beheshti University of Medical Sciences

  t  

Address: Tajrish Sq., Shohada-e-Tajrish Hospital, Tehran, Iran

Tel: +98 21 22 71 22 34
Fax: +98 21 22 72 42 15
Email: mhrhrc@sbmu.ac.ir

        Quick Links

            

Affiliation:

Men's Health and Reproductive Health Research Center , Shahid Beheshti University of Medical Sciences , Tehran, Iran

     
Copyright © 2012 Shahid Beheshti University of Medical Sciences... All rights reserved. | Privacy Policy